Diane E. Wilfong - Jul 11, 2021 Form 4 Insider Report for IMPEL NEUROPHARMA INC (IMPL)

Role
Director
Signature
/s/ John Leaman, M.D. as attorney-in-fact
Stock symbol
IMPL
Transactions as of
Jul 11, 2021
Transactions value $
$0
Form type
4
Date filed
7/13/2021, 05:12 PM
Next filing
Aug 12, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMPL Stock Option (right to buy) Award $0 +11.5K $0.00 11.5K Jul 11, 2021 Common Stock 11.5K $9.96 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is 100% vested on July 11, 2022.